These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 363599)

  • 21. Studies of migration inhibition tests in penicillin hypersensitivity.
    Warrington RJ; Sauder PJ; Rutherford WJ
    Clin Exp Immunol; 1979 Oct; 38(1):148-57. PubMed ID: 393437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The adjuvant activity of mycobacterial RNA preparations and synthetic polynucleotides for induction of delayed hypersensitivity to purified protein derivative in guinea pigs.
    Casavant CH; Youmans GP
    J Immunol; 1975 Mar; 114(3):1014-22. PubMed ID: 803534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.
    Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ
    Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole.
    Daniels JC; Warren KS; David JR
    J Immunol; 1975 Nov; 115(5):1414-21. PubMed ID: 51891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desensitization: effects on cutaneous and peritoneal manifestations of delayed hypersensitivity in relation to lymphokine production.
    Sonozaki H; Papermaster V; Yoshida T; Cohen S
    J Immunol; 1975 Dec; 115(6):1657-61. PubMed ID: 1102607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fractionation of antigen-dependent macrophage migration inhibition and macrophage activation factors from lymph draining a tuberculin reaction.
    Lowe DM; Lachmann PJ
    Scand J Immunol; 1974; 3(4):423-32. PubMed ID: 4605265
    [No Abstract]   [Full Text] [Related]  

  • 27. Partial purification and chemical characterization of macrophage cytotoxicity factor (MCF, MAF) and its separation from migration inhibitory factor (MIF).
    Kniep EM; Domzig W; Lohmann-Matthes ML; Kickhöfen B
    J Immunol; 1981 Aug; 127(2):417-22. PubMed ID: 6166671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. III. Generation of monoclonal antibody specific for human MIF.
    Fahlbusch B; Schumann I
    Biomed Biochim Acta; 1987; 46(5):397-406. PubMed ID: 3311040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of guinea pig pH 3 migration inhibitory factor.
    Remold HG; McCarthy PL; Mednis AD
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4088-91. PubMed ID: 7027252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity.
    Geczy CL; Meyer PA
    J Immunol; 1982 Jan; 128(1):331-6. PubMed ID: 6172485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte chemotaxis in inflammation. VII. Isolation and purification of chemotactic factors for T lymphocytes from PPD-induced delayed hypersensitivity skin reaction site in the guinea-pig.
    Shimokawa Y; Harita S; Hayashi H
    Immunology; 1984 Feb; 51(2):275-85. PubMed ID: 6607210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-yield expression and purification of recombinant human macrophage migration inhibitory factor.
    Mozetic-Francky B; Cotic V; Ritonja A; Zerovnik E; Francky A
    Protein Expr Purif; 1997 Feb; 9(1):115-24. PubMed ID: 9116493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Suppression of the intradermal hypersensitivity reaction of the delayed type by a serum fraction from patients containing leukocyte migration inhibition factor].
    Gorbach AD; Novikov DK; Gorbach IN
    Biull Eksp Biol Med; 1978 Apr; 85(4):457-60. PubMed ID: 350308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial purification of guinea pig MIF by affinity column chromatography using macrophages.
    Onozaki K; Haga S; Miura K; Hashimoto T
    Microbiol Immunol; 1979; 23(6):533-41. PubMed ID: 114736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.
    Tadakuma T; Kühner AL; Rich RR; David JR; Pierce CW
    J Immunol; 1976 Jul; 117(1):323-30. PubMed ID: 6595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig.
    Postlethywaite AE; Townes AS; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1716-20. PubMed ID: 794416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two migration inhibitory factors with different chromatographic behavior and isoelectric points.
    Remold HG; Mednis AD
    J Immunol; 1977 Jun; 118(6):2015-9. PubMed ID: 325133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage migration inhibitory factor (MIF) produced by a human T cell hybridoma clone.
    Oki S; Hirose S; Higuchi M; Osawa T
    Lymphokine Cytokine Res; 1991 Aug; 10(4):273-80. PubMed ID: 1932371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice.
    Levy JG; Smith AG; Whitney RB; McMaster R; Kilburn DG
    Immunology; 1976 Apr; 30(4):565-73. PubMed ID: 131782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between inhibition of indicator cell migration and tuberculin hypersensitivity in patients with suspected tuberculous inflammation of the uveal tissue.
    Kalafut F; Cernák A
    Folia Biol (Praha); 1977 Jan; 23(1):40-7. PubMed ID: 66161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.